New Technology Department was established as a natural expansion of Bienta and currently provides services for Recombinant Proteins Production and Screening by Mass Spectrometry.

The Screening Group provides hit identification and hit-to-lead optimization contract services to the biotech and pharmaceutical industry. We are also open to discuss shared-risk exploratory hit finding projects with the industry or academic partners… (more…)

In 2011, Enamine announced the opening of a contract research laboratory (CRO) for biological screening and ADMET testing services at its leading research site in Kyiv, Ukraine. Since June 2013, Enamine’s biological testing services are offered under a trademark of Bienta. (more…)

The growing Bienta currently employs 83 FTEs and is capable of performing HTS with a broad variety of biochemical and cell-based assays. (more…)